Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2
- 1 October 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (10) , 1169-1179
- https://doi.org/10.1038/modpathol.3800196
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cellsHepatology, 2002
- Hepatitis B Virus X Protein Acts as a Tumor Promoter in Development of Diethylnitrosamine-Induced Preneoplastic LesionsJournal of Virology, 2001
- Redundancy in the Signaling Pathways and Promoter Elements Regulating Cyclooxygenase-2 Gene Expression in Endotoxin-treated Macrophage/Monocytic CellsJournal of Biological Chemistry, 2001
- Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinomaGut, 2001
- Cyclooxygenases: Structural, Cellular, and Molecular BiologyAnnual Review of Biochemistry, 2000
- Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomasHepatology, 1998
- Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial CellsJournal of Biological Chemistry, 1997
- HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosisHepatology, 1991
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981